Primary Record
Gliquidone
- In stock
- 811 g
- Purity
- 99.0 %
- CAS
- 33342-05-1
Compound Identifiers & Properties
- CAS
- 33342-05-1
- PubChem CID
- 91610
- SMILES
- CC1(C2=C(C=C(C=C2)OC)C(=O)N(C1=O)CCC3=CC=C(C=C3)S(=O)(=O)NC(=O)NC4CCCCC4)C
- Canonical SMILES
- COc1ccc2c(c1)C(=O)N(CCc1ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc1)C(=O)C2(C)C
Names & Synonyms
- Gliquidone
- Glurenorm
- Gliquidonum
- 33342-05-1
- Gliquidona
- Beglynor
- glikvidon
- glycvidon
- Beglynora
- Gliquidon
- Gliquidone sodium
- Glurenor
- Glurenorm sodium
- Glurenor;
- Glurenorm (TN)
- ARDF 26
- Gliquidone (INN)
- gliquidone calcium
- Gliquidonum [INN-Latin]
- Gliquidona [INN-Spanish]
- Gliquidone [BAN:INN]
- gliquidone monosodium
- Gliquidone, 98%
- ARDF 26 SE
- ARDF-26
- Gliquidone [INN:BAN]
- AR-DF 26 sodium
- Gliquidone (Standard)
- C27H33N3O6S
- C7C2QDD75P
- GLIQUIDONE [MI]
- gliquidone, calcium salt
- UNII-C7C2QDD75P
- AC1L3MFD
- GLIQUIDONE [INN]
- Prestwick0_000991
- Prestwick1_000991
- Prestwick2_000991
- Prestwick3_000991
- RefChem:143382
- AR-DF 26
- DTXSID4023096
- D06HBQ
- gliquidone, monosodium salt
- GLIQUIDONE [MART.]
- DTXCID403096
- GLIQUIDONE [WHO-DD]
- MFCD00631870
- Oprea1_069443
- SCHEMBL37769
- BSPBio_001081
- MLS000881123
- MLS000881174
- MLS002154087
- C27H32N3O6S.Na
- EINECS 251-463-2
- SPBio_002972
- AR-DF-26
- BPBio1_001191
- CHEMBL383634
- orb1310680
- SCHEMBL29465034
- CHEBI:93416
- CTK8B3534
- HY-B1114R
- KS-00000XIQ
- ZINC1482077
- A10BB08
- BRN 1559726
- LLJFMFZYVVLQKT-UHFFFAOYSA-N
- BDBM682047
- GLXC-07324
- HMS1571G03
- HMS2098G03
- HMS2964J06
- HMS3652O05
- HMS3715G03
- HMS5081I20
- ACT06290
- BCP11927
- CID91610
- HY-B1114
- MSK10097
- C27-H32-N3-O6-S.Na
- GLIQUIDONE (REFERENCE GRADE)
- Tox21_110629
- ANW-42682
- BDBM50248247
- C27-H33-N3-O6-S
- CG0041
- CID:91610
- EBC-06092
- NCGC00016819-01
- NP3401
- AKOS001037880
- Tox21_110629_1
- CCG-220991
- CM14378
- CS-4646
- CS-O-01599
- DB01251
- FG40551
- KS-5239
- CAS-33342-05-1
- NCGC00016819-02
- NCGC00016819-03
- NCGC00016819-05
- NCGC00016819-06
- NCGC00179315-01
- AC-23356
- AK343641
- BC214705
- J19.880C
- LS-31460
- SC-13574
- SMR000685793
- 1-cyclohexyl-3-[4-[2-(7-methoxy-4,4-dimethyl-1,3-dioxoisoquinolin-2-yl)ethyl]phenyl]sulfonylurea
- 3-Cyclohexyl-1-[4-[2-(7-methoxy-4,4-dimethyl-1,3-dioxo-isoquinolin-2-yl)ethyl]phenyl]sulfonyl-urea
- SID:170467343
- DB-366405
- LS-159650
- TL8002523
- TR-013968
- AB00513989
- B2196
- FT-0630570
- G0332
- NS00007815
- S3151
- SW197285-3
- US20240207249, Inhibitor ID AD12
- N-(Cyclohexylcarbamoyl)-4-(2-(7-methoxy-4,4-dimethyl-1,3-dioxo-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)benzenesulfonamide
- D02430
- EN300-708770
- J10245
- T72318
- AB00513989_07
- 342G051
- A821736
- C010969
- SR-01000833866
- 3-cyclohexyl-1-[4-[2- ethyl]phenyl]sulfonyl-urea
- I06-0185
- Q5569924
- SR-01000833866-2
- BRD-K80396088-001-03-9
- BRD-K80396088-001-12-0
- Gliquidone, 98%, an anti-diabetic compound - 1G 1g
- Z56785257
- 1-Cyclohexyl-3-(p-beta-(4,4-dimethyl-2-methoxy-1,3-(2H,4H)-isoquinolinedione-2-yl)phenethyl)sulfonylurea
- 62783-47-5
- 1-Cyclohexyl-3-((p-(2-(3,4-dihydro-7-methoxy-4,4-dimethyl-1,3-dioxo-2(1H)-isoquinolyl)ethyl)phenyl)sulfonyl)urea
- 1-cyclohexyl-3-({4-[2-(7-methoxy-4,4-dimethyl-1,3-dioxo-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]benzene}sulfonyl)urea
- Benzenesulfonamide, N-((cyclohexylamino)carbonyl)-4-(2-(3,4-dihydro-7-methoxy-4,4-dimethyl-1,3-dioxo-2(1H)-isoquinolinyl)ethyl)-
- 1-cyclohexyl-3-(p-beta-(4,4- dimethyl-2-methoxy-1,3-(2H,4H)-isoquinolinedione- 2-yl)phenethyl)sulfonylurea
- 1-cyclohexyl-3-{4-[2-(7-methoxy-4,4-dimethyl-1,3-dioxo-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]benzenesulfonyl}urea
- N-[(cyclohexylamino)carbonyl]-4-[2-(3,4-dihydro-7-methoxy-4,4-dimethyl-1,3-dioxoisoquinolin-2(1h)-yl)ethyl]benzenesulfonamide
- N-[(cyclohexylamino)carbonyl]-4-{2-[4,4-dimethyl-7-(methyloxy)-1,3-dioxo-3,4-dihydroisoquinolin-2(1H)-yl]ethyl}benzenesulfonamide
- 1-CYCLOHEXYL-3-(((P-(2-(3,4-DIHYDRO-7-METHOXY-4,4-DIMETHYL-1,3-DIOXO-2(1H)-ISOQUINOLYL)ETHYL)PHENYL)SULFONYL)UREA
- 1-cyclohexyl-3-[4-[2-(7-methoxy-4,4-dimethyl-1,3-dioxo-2-isoquinolinyl)ethyl]phenyl]sulfonylurea
- 1-cyclohexyl-3-[4-[2-(7-methoxy-4,4-dimethyl-1,3-dioxo-2-isoquinolyl)ethyl]phenyl]sulfonyl-urea
- 251-463-2
- 3-cyclohexyl-1-((4-(2-(7-methoxy-4,4-dimethyl-1,3-dioxo-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl)benzene)sulfonyl)urea
- 3-cyclohexyl-1-({4-[2-(7-methoxy-4,4-dimethyl-1,3-dioxo-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]benzene}sulfonyl)urea
- 3-Cyclohexyl-1-[4-[2-(7-methoxy -4,4-dimethyl-1,3-dioxo-isoquinolin -2-yl)ethyl]phenyl]sulfonyl-urea
- 3-cyclohexyl-1-{4-[2-(7-methoxy-4,4-dimethyl-1,3-dioxoisoquinolin-2-yl)ethyl]benzenesulfonyl}urea
- Benzenesulfonamide, N-((cyclohexylamino)carbonyl)-4-(2-(3,4-dihydro-7-methoxy-4,4-dimethyl-1,3-dioxo-2(1H)-isoquinolinyl)ethyl)-, sodium salt
- Benzenesulfonamide, N-[(cyclohexylamino)carbonyl]-4-[2-(3,4-dihydro-7-methoxy-4,4-dimethyl-1,3-dioxo-2(1H)-isoquinolinyl)ethyl]-
- Benzenesulfonamide, N-[(cyclohexylamino)carbonyl]-4-[2-(3,4-dihydro-7-methoxy-4,4-dimethyl-1,3-dioxo-2(1H)-isoquinolinyl)ethyl]-, monosodium salt
- Benzenesulfonamide, N-[(cyclohexylamino)carbonyl]-4-[2-(3,4-dihydro-7-methoxy-4,4-dimethyl-1,3-dioxo-2(1H)-isoquinolinyl)ethyl]-; AR-DF 26; ARDF 26SE; Beglynor; Gliquidone; Glurenorm
- N-(Cyclohexylcarbamoyl)-4-[2-(7-methoxy-4,4-dimethyl-1,3-dioxo-3,4-dihydroisoquinolin-2(1H)-yl)ethyl]benzene-1-sulfonamide
- N-cyclohexylcarbamoyl-4-[2-(7-methoxy-4,4-dimethyl-1,3-dioxo-1,2,3,4- tetrahydroisoquinolin-2-yl)ethyl]benzenesulfonamide